Search research articles
Contact Us
Filters
Showing results (671-680 of 760) with videos related to
Page
of 76
Sort By:
Annals of Surgical Oncology
|
January 20, 2012
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy
Ching-Wei D Tzeng, Jason B Fleming, Jeffrey E Lee, et al.
Cancer
|
December 20, 2011
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation
Jiansheng Wang, Jeannelyn S Estrella, Lan Peng, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
Ching-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Frontiers in Nutrition
|
April 10, 2023
Single hair analysis by X-ray fluorescence spectrometry detects small changes in dietary zinc intake: A nested randomized controlled trial
Christopher J Frederickson, David E B Fleming, Dan Asael, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
October 6, 2022
Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort Study
Benjamin D Powers, James McDonald, Rahul Mhaskar, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 31, 2012
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection
Ryan M Thomas, Mark J Truty, Graciela M Nogueras-Gonzalez, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 17, 2013
Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer
Hop S Tran Cao, Alpana Balachandran, Huamin Wang, et al.
Annals of Surgical Oncology
|
December 19, 2014
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer
Amanda B Cooper, Rebecca Slack, David Fogelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
T M Breslin, L Cohen, A Sahin, et al.
Journal of Proteome Research
|
May 24, 2019
Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer
Prasanta Dutta, Mayrim R Perez, Jaehyuk Lee, et al.
Page
of 76
Search research articles
Search
Showing results (671-680 of 760) with videos related to
Sort By:
Page
of 76
Annals of Surgical Oncology
|
January 20, 2012
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy
Ching-Wei D Tzeng, Jason B Fleming, Jeffrey E Lee, et al.
Cancer
|
December 20, 2011
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation
Jiansheng Wang, Jeannelyn S Estrella, Lan Peng, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
Ching-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Frontiers in Nutrition
|
April 10, 2023
Single hair analysis by X-ray fluorescence spectrometry detects small changes in dietary zinc intake: A nested randomized controlled trial
Christopher J Frederickson, David E B Fleming, Dan Asael, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
October 6, 2022
Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort Study
Benjamin D Powers, James McDonald, Rahul Mhaskar, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 31, 2012
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection
Ryan M Thomas, Mark J Truty, Graciela M Nogueras-Gonzalez, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 17, 2013
Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer
Hop S Tran Cao, Alpana Balachandran, Huamin Wang, et al.
Annals of Surgical Oncology
|
December 19, 2014
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer
Amanda B Cooper, Rebecca Slack, David Fogelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
T M Breslin, L Cohen, A Sahin, et al.
Journal of Proteome Research
|
May 24, 2019
Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer
Prasanta Dutta, Mayrim R Perez, Jaehyuk Lee, et al.
Page
of 76